Thomas Nieuwenstein, BSc Biomedical Sciences Human Immunodeficiency Virus (HIV) treatment has come a long way since the introduction of the first anti-HIV treatment – azidothymidine, or better known as zidovudine, a nucleoside reverse transcriptase inhibitor – in 1987 [1]. While the drug proved to be effective at reducing opportunistic infections and AIDS-related deaths, it caused severe adverse effects in the patient population [1]. Since then, new drugs have been developed which have turned … [Lees meer...]
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Aangedreven door 